Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Simex
- Development stage
- Unknown
- Lead developer
- Grievers Remedies
- Administration
- Oral
01
Overview
**Simex** is an orally administered herbal cough syrup marketed by Grievers Remedies in India for cough. Public product-listing information identifies it as a herbal cough syrup, but does not disclose its botanical ingredients, standardized extract composition, pharmacologic targets, or specific mechanism of action. ([indiamart.com](https://www.indiamart.com/grievers-remidies/products-and-services.html))
- Brand names
- Simex
Beyond the preview
Go deeper on Simex.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Simex.